The Endoscope Reprocessing Market is expected to grow at a 9.26% compound annual growth rate (CAGR) from 2024 to 2032, from its valuation of USD 1.62 billion in 2023 to USD 3.59 billion.
To Get more information on Endoscope Reprocessing Market - Request Free Sample Report
This report indicates the local prevalence of endoscopy-related infection and ongoing demand for rigorous reprocessing procedures. The research considers the number of endoscopes available and their utilization frequency in various healthcare settings such as hospitals, surgical facilities, and clinics, demonstrating a need to uphold tight cleaning standards. Moreover, the report examines regulatory compliance and accreditation trends, with increasing compliance with CDC guidelines and Joint Commission standards transforming institutional practices. We also examine healthcare expenditures on infection control, breaking it down by region and payer type to uncover disparities in funding and prioritization. The base of endoscope reprocessing systems installed experiences steady growth among regions from 2020 to 2032, further sustained by upcoming trends for reprocessing staff training and certification to reduce human error.
The US Endoscope Reprocessing Market is expected to grow at a compound annual growth rate (CAGR) of 8.38% during the period 2024-2032, from its 2023 value of USD 0.48 billion to USD 0.98 billion. In the United States, the market is driven by strong regulatory control, rising investment in automated reprocessing technologies, and a stronger focus on staff credentialing to prevent patient harm and minimize hospital-acquired infections.
Drivers
The increasing number of endoscopic procedures and rising awareness of infection control are majorly fueling the demand for endoscope reprocessing systems.
The number of endoscopic procedures is rising globally, with a rising tide of gastrointestinal, respiratory, and urological illnesses. For example, based on the American Society for Gastrointestinal Endoscopy, more than 20 million GI endoscopies are carried out every year in the U.S. alone. This increased volume requires stringent reprocessing criteria to avoid cross-contamination and healthcare-associated infections (HAIs). Furthermore, there is increasing compliance with regulations published by agencies like the CDC, AAMI, and the Joint Commission that focus on high-level disinfection (HLD) and traceability in reprocessing processes. Hospitals and ambulatory centers increasingly use automated endoscope reprocessors (AERs) for compliance and to reduce human error. The increase in multidrug-resistant organisms (MDROs) and endoscope-related infection outbreaks, like the duodenoscope-associated CRE (Carbapenem-resistant Enterobacteriaceae) cases, has also spurred investments in sophisticated reprocessing equipment. In addition, the incorporation of digital traceability technologies, leak testing, and drying cabinets is being prioritized to enhance safety. Overall, these trends are driving healthcare facilities to upgrade and enhance their reprocessing capacity, infection prevention, and equipment longevity as a central operational imperative.
Restraints
The market is hampered by the high initial and operating expenses of endoscope reprocessing devices despite increasing demand.
An important limitation to the use of advanced endoscope reprocessing machines on a large scale is the requirement of substantial capital investment, particularly for automated models. Automated Endoscope Reprocessors (AERs), drying ovens, and sophisticated tracking systems can range in price from USD 30,000 to USD 70,000 per machine, excluding installation and regular maintenance costs. For community hospitals and outpatient facilities, especially in Third World countries, these costs can be expensive. Additionally, reprocessing involves not just the equipment but also regular use of disinfectants, enzymatic detergents, water purification systems, and sterilization accessories, which contribute to ongoing expenses. The sophistication of the systems also involves heavy investment in personnel training and certification courses, which again strain budgets. Another important cost consideration is compliance with ever-tighter regulations, which usually means that facilities must upgrade equipment to keep pace with changing standards. Although cost savings in the long run are usually mentioned, the initial expense hurdle deters smaller providers from making the shift from manual to automated systems. Consequently, manual reprocessing, which is more prone to contamination and human error, remains in use, constraining the wider market penetration of more efficient reprocessing technologies.
Opportunities
Automation integration and technological evolution provide new channels for growth toward enhancing endoscope reprocessing efficacy and safety.
With infection prevention emerging as a top focus in healthcare, the need for intelligent, data-driven reprocessing systems is presenting fertile ground for innovation. Industries are increasingly introducing reprocessors equipped with real-time cycle monitoring, barcode-based traceability, and automated leak checking. One prominent avenue includes the convergence of artificial intelligence (AI) and Internet of Things (IoT) technologies to streamline processes and enhance safety compliance. AI can assist in reprocessing data analysis to identify process deviations, anticipate maintenance requirements, and enhance turnaround time. For instance, AI-powered dashboards can notify technicians if a particular scope hasn't finished a required step, minimizing the likelihood of human error. In addition, intelligent drying and storage cabinets with HEPA filtration and humidity detection keep scopes sterile after reprocessing. Advances in sustainable chemical formulations and water conservation also contribute to sustainability objectives, presenting manufacturers with a new value proposition. Increased emphasis on centralized sterile processing departments (CSPDs) within large hospitals also presents opportunities for packaged, scalable solutions. As regulations become more stringent, hospitals will increasingly employ intelligent, closed-loop reprocessing systems that offer ready-to-audit records, resulting in a high demand for digital and automated solutions.
Challenges
Although there have been advances in technology, the reprocessing process is still prone to mistakes owing to its complexity and reliance on trained staff.
The endoscope reprocessing process is complex, encompassing numerous steps—pre-cleaning, leak testing, manual cleaning, disinfection or sterilization, rinsing, drying, and storage. Every step has to be performed in precise adherence to manufacturer instructions and infection control guidelines. Even a minor departure from these can affect patient safety. A 2022 article in Infection Control & Hospital Epidemiology reported that as many as 25% of flexible endoscopes used regularly could be reprocessed incorrectly because of human mistakes or a lack of proper training. With or without automation, some steps, particularly manual cleaning, are still dependent on staff consistency and accuracy. The difficulty increases in high-volume hospitals where personnel shortages, shift changes, and fatigue exacerbate the risk of incomplete reprocessing. Also, differences in endoscope design, such as from duodenoscopes to bronchoscopes, require special handling, rendering universal reprocessing protocols challenging. Regulatory compliance audits and inspections also put pressure on facilities with insufficient administrative support or digital monitoring. Even with AI-based systems, without proper training and process standardization, errors continue. Thus, achieving seamless, error-free reprocessing remains a big challenge, especially in cost-constrained or short-staffed healthcare settings.
By Product
High-Level Disinfectants and Test Strips contributed the maximum revenue share of 28.8% in 2023, leading the market because of their pivotal position in the fundamental disinfection process. These are crucial for endoscope reprocessing safety and efficacy, particularly considering the increased concerns related to endoscopy-associated infections. High-level disinfectants, including glutaraldehyde, peracetic acid, and ortho-phthalaldehyde (OPA), are used extensively because of their broad-spectrum antimicrobial action. Test strips, however, provide proper monitoring of disinfectant concentration levels, and this improves infection control protocol compliance. The prevalent use of manual reprocessing in most healthcare facilities also supports the high demand for these products.
The Automated Endoscope Reprocessors (AERs) segment is expected to expand at the highest rate during the forecast period. This expansion is a result of increased movement toward automated processes to decrease human error and enhance reprocessing consistency. AERs provide validated, reproducible, standardized cleaning and disinfection cycles with low risk for contamination. Under increasing regulatory and hospital accreditation initiatives, healthcare environments are investing heavily in AERs to remain compliant with infection prevention guidelines as well as maintain streamlined workflows.
By End-Use
Outpatient facilities dominated the market with the highest revenue share of 55.6% in 2023, spurred by the rise in minimally invasive procedures conducted outside of the hospital. Specialty clinics and ambulatory surgical centers need cost-efficient and economical reprocessing solutions because of increased patient throughput. The growth of outpatient GI and urology facilities at a rapid rate has also driven demand for smaller, rapid-turnaround reprocessing systems. In addition, the lower operating and infrastructure costs in outpatient facilities make them preferable for regular diagnostic endoscopy, increasing segment dominance further.
At the same time, hospitals are projected to be the highest-growing segment, fueled by growing use of centralized reprocessing units and increased procedural sophistication in tertiary care. Hospitals handle a wider variety of endoscope types, such as sophisticated devices like duodenoscopes and bronchoscopes, which necessitate sophisticated reprocessing systems and rigorous compliance. Further, hospitals face mounting pressure to meet rigorous infection control requirements and regulatory audits, leading to investments in high-end AERs, traceability systems, and drying/storage technologies.
North America was the leading player in the endoscope reprocessing market in 2023, owing to the well-developed healthcare infrastructure, stringent infection control standards, and high procedural volumes in the region. The extensive utilization of advanced reprocessing equipment in U.S. and Canadian hospitals and outpatient facilities has been a major driver for market growth. Moreover, regulatory agencies like the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) still urge tighter compliance with reprocessing procedures, pushing facilities to implement automated systems and digital traceability solutions. Industry leaders are also headquartered in this region, fueling innovation and quicker technology adoption.
Europe is expected to exhibit the highest growth rate in the forecast period due to rising healthcare spending, heightened awareness regarding healthcare-associated infections (HAIs), and the rising volume of endoscopic procedures in Germany, the U.K., France, and Italy. Regulatory focus from associations such as the European Society of Gastrointestinal Endoscopy (ESGE) is also increasing the use of high-level disinfection and AERs. Furthermore, continued hospital infrastructure modernization and deployment of centralized sterile processing units are driving endoscope reprocessing systems demand forward at a rapid pace. Increasing investment in AI-driven reprocessing and compliance software further makes Europe the central growth nexus in the world market.
Get Customized Report as per Your Business Requirement - Enquiry Now
Cantel Medical – Advantage Plus, Rapicide OPA-28, RapidAER, BioShield Scope Transport System
Fortive Corporation (Advanced Sterilization Products - ASP) – EVOTECH Endoscope Cleaner and Reprocessor, CIDEZYME XTRA Enzymatic Detergent, CIDEX OPA Solution
Olympus Corporation – OER-Pro, ETD Double Endoscope Washer Disinfector, OFP Endoscope Flushing Pump, Olympus Storage Cabinets
Ecolab – Sekusept, Soluscope Cleaner and Disinfectants, Revital-Ox RESERT High-Level Disinfectant, Revital-Ox Enzymatic Detergent
Getinge AB – ED-Flow, GSS67H Washer Disinfectors, Getinge Assured Wash Monitors
STERIS – Reliance Endoscope Reprocessors, SYSTEM 1 Express Sterile Processing System, Verify Cleanliness Indicators, EndoDry Drying and Storage System
Steelco S.p.A. – EW 1 S MAXI, DS 610 CL, ED 100 Drying Cabinet
ARC Group of Companies Inc. – Enzymatic Cleaners, High-Level Disinfectants, Scope Transport & Storage Solutions
Metrex Research, LLC. – MetriCide OPA Plus, EmPower Enzymatic Detergent, CaviWipes
Shinva Medical Instrument Co., Ltd. – WD-GI Series Endoscope Washer Disinfector, WD-E Series, Endoscope Drying Cabinets
Belimed – WD 290 IQ, ECS Scope Reprocessors, Scope Drying and Storage Cabinets
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 1.62 billion |
| Market Size by 2032 | USD 3.59 billion |
| CAGR | CAGR of 9.26% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product [High-Level Disinfectants And Test Strips, Detergents And Wipes, Automated Endoscope Reprocessors (AERs), Endoscope Drying, Storage, And Transport Systems, Others] • By End-Use [Hospitals, Outpatient Facilities] |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Cantel Medical, Fortive Corporation (Advanced Sterilization Products - ASP), Olympus Corporation, Ecolab, Getinge AB, STERIS, Steelco S.p.A, ARC Group of Companies Inc., Metrex Research, LLC, Shinva Medical Instrument Co., Ltd., Belimed. |
Ans: The Endoscope Reprocessing Market is projected to grow at a CAGR of 9.26% during the forecast period.
Ans: By 2032, the Endoscope Reprocessing Market is expected to reach USD 3.59 billion, up from USD 1.62 billion in 2023.
Ans: The increasing number of endoscopic procedures and rising awareness of infection control are majorly fueling the demand for endoscope reprocessing systems.
Ans: The market is hampered by the high initial and operating expenses of endoscope reprocessing devices despite increasing demand.
Ans: North America is the dominant region in the Endoscope Reprocessing Market
Table of contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence of Endoscopy-Associated Infections (2023), by Region
5.2 Endoscope Inventory and Utilization Rate, by Healthcare Setting (Hospitals, ASCs, Clinics), 2023
5.3 Regulatory Compliance & Accreditation Penetration (e.g., Joint Commission, CDC Guidelines), 2023
5.4 Healthcare Spending on Infection Control (2023), by Region and Payer Type (Government, Private, Out-of-Pocket)
5.5 Installed Base of Endoscope Reprocessing Systems, by Region (2020–2032)
5.6 Trends in Reprocessing Staff Training & Certification, 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Service Benchmarking
6.3.1 Service specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Service launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Endoscope Reprocessing Market Segmentation, by Product
7.1 Chapter Overview
7.2 High-Level Disinfectants And Test Strips
7.2.1 High-Level Disinfectants And Test Strips Market Trends Analysis (2020-2032)
7.2.2 High-Level Disinfectants And Test Strips Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Detergents And Wipes
7.3.1 Detergents And Wipes Market Trends Analysis (2020-2032)
7.3.2 Detergents And Wipes Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Automated Endoscope Reprocessors (AERs)
7.4.1 Automated Endoscope Reprocessors (AERs) Market Trends Analysis (2020-2032)
7.4.2 Automated Endoscope Reprocessors (AERs) Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Endoscope Drying, Storage, And Transport Systems
7.5.1 Endoscope Drying, Storage, And Transport Systems Market Trends Analysis (2020-2032)
7.5.2 Endoscope Drying, Storage, And Transport Systems Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Endoscope Reprocessing Market Segmentation, by End-Use
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Outpatient Facilities
8.3.1 Outpatient Facilities Market Trends Analysis (2020-2032)
8.3.2 Outpatient Facilities Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Endoscope Reprocessing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.4 North America Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.5.2 USA Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.6.2 Canada Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Mexico Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Endoscope Reprocessing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.5.2 Poland Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.6.2 Romania Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Endoscope Reprocessing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.4 Western Europe Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.5.2 Germany Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.6.2 France Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.7.2 UK Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.8.2 Italy Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.9.2 Spain Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.12.2 Austria Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Endoscope Reprocessing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.4 Asia Pacific Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 China Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 India Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.5.2 Japan Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.6.2 South Korea Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.2.7.2 Vietnam Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.8.2 Singapore Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.9.2 Australia Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Endoscope Reprocessing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.4 Middle East Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.5.2 UAE Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Endoscope Reprocessing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.4 Africa Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Endoscope Reprocessing Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.4 Latin America Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.5.2 Brazil Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.6.2 Argentina Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.7.2 Colombia Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Endoscope Reprocessing Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Endoscope Reprocessing Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10. Company Profiles
10.1 Cantel Medical
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
10.1.4 SWOT Analysis
10.2 Fortive Corporation (Advanced Sterilization Products - ASP)
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Olympus Corporation
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Ecolab
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Getinge AB
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 STERIS
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Steelco S.p.A
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 ARC Group of Companies Inc.
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Metrex Research, LLC
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Shinva Medical Instrument Co., Ltd.
10.10.1 Company Overview
10.10.2 Financial
10.10.3 Products/ Services Offered
10.10.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Product
High-Level Disinfectants And Test Strips
Detergents And Wipes
Automated Endoscope Reprocessors (AERs)
Endoscope Drying, Storage, And Transport Systems
Others
By End-Use
Hospitals
Outpatient Facilities
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country-Level Research Report: Country-Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g., Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Immunoprotein Diagnostic Testing Market size was valued at USD 8.89 billion in 2023, expected to reach USD 17.13 billion by 2032, growing at a 7.54%.
The Artificial Tears Market size was USD 3.09 Billion in 2023 and is expected to reach USD 5.94 Billion by 2032 and grow at a CAGR of 7.55% over the forecast period of 2024-2032.
The Gene Therapy Market Size was valued at USD 9.2 Billion in 2023, and is expected to reach USD 54.39 Billion by 2032, and grow at a CAGR of 23.12%.
Laboratory Equipment Market valued at USD 30.9 billion in 2023, projected to reach USD 60.25 billion by 2032, growing at a CAGR of 7.7% from 2024-2032.
The Knee Replacement Market size was valued at USD 10.61 billion in 2023 and is projected grow to at a CAGR of 4.98% to reach USD 16.41 billion by 2032
The Patient Registry Software Market Size was valued at USD 1.75 Billion in 2023 and is expected to reach USD 5.23 Billion by 2032, growing at a CAGR of 12.93% over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
